Volume 15; Issue 11

Main
The Lancet Oncology
Volume 15; Issue 11

The Lancet Oncology

Volume 15; Issue 11

1

Hypoxia-activated TH-302 for advanced soft-tissue sarcoma

Rahman, Ahmadur

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 126 KB

english, 2014

2

Can we have a better death?

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 982 KB

english, 2014

3

Prevention and early detection of prostate cancer

Cuzick, Jack, Thorat, Mangesh A, Andriole, Gerald, Brawley, Otis W, Brown, Powel H, Culig, Zoran, Eeles, Rosalind A, Ford, Leslie G, Hamdy, Freddie C, Holmberg, Lars, Ilic, Dragan, Key, Timothy J, Vec

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 302 KB

english, 2014

4

Be a man—and apologise

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 417 KB

english, 2014

5

Laws on medical cannabis lower opioid overdose mortality

Bagcchi, Sanjeet

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 97 KB

english, 2014

6

Patient priority in the era of patent expiries

Horning, Sandra

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 37 KB

english, 2014

7

Bevacizumab alone or in combination with chemotherapy in glioblastomas?–Authors' reply

van den Bent, Martin J, Taal, Walter

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 43 KB

english, 2014

8

Lenalidomide in transplant-ineligible myeloma

Bagcchi, Sanjeet

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 187 KB

english, 2014

9

Knowledge, attitudes, and behaviours towards cancer screening in indigenous populations: a systematic review

Kolahdooz, Fariba, Jang, Se Lim, Corriveau, André, Gotay, Carolyn, Johnston, Nora, Sharma, Sangita

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 218 KB

english, 2014

10

Erlotinib alone or with bevacizumab as first-line therapy in patients with advanced non-squamous non-small-cell lung cancer harbouring EGFR mutations (JO25567): an open-label, randomised, multicentre, phase 2 study

Seto, Takashi, Kato, Terufumi, Nishio, Makoto, Goto, Koichi, Atagi, Shinji, Hosomi, Yukio, Yamamoto, Noboru, Hida, Toyoaki, Maemondo, Makoto, Nakagawa, Kazuhiko, Nagase, Seisuke, Okamoto, Isamu, Yaman

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 398 KB

english, 2014

11

Cumulative alkylating agent exposure and semen parameters in adult survivors of childhood cancer: a report from the St Jude Lifetime Cohort Study

Green, Daniel M, Liu, Wei, Kutteh, William H, Ke, Raymond W, Shelton, Kyla C, Sklar, Charles A, Chemaitilly, Wassim, Pui, Ching-Hon, Klosky, James L, Spunt, Sheri L, Metzger, Monika L, Srivastava, Deo

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 261 KB

english, 2014

12

Risk of infertility in male survivors of childhood cancer

Brannigan, Robert E

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 182 KB

english, 2014

13

Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial

von Minckwitz, Gunter, Puglisi, Fabio, Cortes, Javier, Vrdoljak, Eduard, Marschner, Norbert, Zielinski, Christoph, Villanueva, Cristian, Romieu, Gilles, Lang, István, Ciruelos, Eva, De Laurentiis, Mic

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 297 KB

english, 2014

14

Real-world experience with abiraterone

Dahut, William L, Madan, Ravi A

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 221 KB

english, 2014

15

What new therapeutic targets exist for EGFR-mutant NSCLC?

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 164 KB

english, 2014

16

Pleuropulmonary blastoma early detection improves survival

Bagcchi, Sanjeet

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 125 KB

english, 2014

17

Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study

Liu, Joyce F, Barry, William T, Birrer, Michael, Lee, Jung-Min, Buckanovich, Ronald J, Fleming, Gini F, Rimel, BJ, Buss, Mary K, Nattam, Sreenivasa, Hurteau, Jean, Luo, Weixiu, Quy, Philippa, Whalen,

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 300 KB

english, 2014

18

Emotion-based medicine or evidence-based medicine?

The Lancet Oncology,

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 92 KB

english, 2014

19

Lenalidomide in combination with R-CHOP in lymphoma

Bagcchi, Sanjeet

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 128 KB

english, 2014

20

Adjuvant chemotherapy for patients with rectal cancer?

Breugom, Anne J, van de Velde, Cornelis J H

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 95 KB

english, 2014

21

Combining targeted therapies in ovarian cancer

Scambia, Giovanni, Salutari, Vanda, Ferrandina, Gabriella

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 346 KB

english, 2014

22

Epidemiological differences in haematological malignancies between Europe and China

Chen, Xin-Chuan, Chen, Xin-Zu

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 116 KB

english, 2014

23

Bald Cartoons

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 672 KB

english, 2014

24

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

Wilke, Hansjochen, Muro, Kei, Van Cutsem, Eric, Oh, Sang-Cheul, Bodoky, György, Shimada, Yasuhiro, Hironaka, Shuichi, Sugimoto, Naotoshi, Lipatov, Oleg, Kim, Tae-You, Cunningham, David, Rougier, Phili

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 498 KB

english, 2014

25

Increases in bilateral mastectomy for breast cancer

Burki, Talha Khan

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 124 KB

english, 2014

26

The optimum duration of front-line chemotherapy

Kotsakis, Athanasios, Georgoulias, Vassilis

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 172 KB

english, 2014

27

Biomarker predicts treatment resistance in prostate cancer

Wilkinson, Emma

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 125 KB

english, 2014

28

Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial

Hong, Yong Sang, Nam, Byung-Ho, Kim, Kyu-pyo, Kim, Jeong Eun, Park, Seong Joon, Park, Young Suk, Park, Joon Oh, Kim, Sun Young, Kim, Tae-You, Kim, Jee Hyun, Ahn, Joong Bae, Lim, Seok-Byung, Yu, Chang

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 568 KB

english, 2014

29

Panobinostat for the treatment of multiple myeloma

Rajkumar, S Vincent

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 270 KB

english, 2014

30

Rituximab for low-grade follicular lymphoma?

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 129 KB

english, 2014

31

Thoracic radiotherapy in small-cell lung cancer

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 65 KB

english, 2014

32

Drug interactions between tyrosine-kinase inhibitors and acid suppressive agents: more than meets the eye–Authors' reply

van Leeuwen, Roelof W F, van Gelder, Teun, Mathijssen, Ron H J, Jansman, Frank G A

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 117 KB

english, 2014

33

Changes and restrictions for nicotine use

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 97 KB

english, 2014

34

The comedy brain cancer manual

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 106 KB

english, 2014

35

Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data

Rossi, Antonio, Chiodini, Paolo, Sun, Jong-Mu, O'Brien, Mary E R, von Plessen, Christian, Barata, Fernando, Park, Keunchil, Popat, Sanjay, Bergman, Bengt, Parente, Barbara, Gallo, Ciro, Gridelli, Cesa

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 431 KB

english, 2014

36

Ramucirumab: second-line therapy for gastric cancer

Sasako, Mitsuru

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 289 KB

english, 2014

37

Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma

Ishitsuka, Kenji, Tamura, Kazuo

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 175 KB

english, 2014

38

BCR-ABL1:ABL predicts outcomes in children with CML

Bagcchi, Sanjeet

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 99 KB

english, 2014

39

Bevacizumab beyond progression in breast cancer

Dirix, Luc Y, Reynolds, Andrew R

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 150 KB

english, 2014

40

Adenoma removal and colorectal cancer mortality

Burki, Talha Khan

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 94 KB

english, 2014

41

Bivalent HPV vaccination effective for adult women

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 99 KB

english, 2014

42

Dignified death from a different perspective

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 65 KB

english, 2014

43

Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial

Sternberg, Cora N, Castellano, Daniel, Daugaard, Gedske, Géczi, Lajos, Hotte, Sebastien J, Mainwaring, Paul N, Saad, Fred, Souza, Ciro, Tay, Miah H, Garrido, José M Tello, Galli, Luca, Londhe, Anil, D

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 201 KB

english, 2014

44

Cancer-related inflammation and treatment effectiveness

Diakos, Connie I, Charles, Kellie A, McMillan, Donald C, Clarke, Stephen J

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 544 KB

english, 2014

45

Drug interactions between tyrosine-kinase inhibitors and acid suppressive agents: more than meets the eye

Yu, Guo, Zheng, Qing-Shan, Wang, Da-Xin, Zhou, Hong-Hao, Li, Guo-Fu

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 45 KB

english, 2014

46

ASCT and high-dose melphalan in multiple myeloma

Sharma, Sharan Prakash

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 187 KB

english, 2014

47

Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial

San-Miguel, Jesús F, Hungria, Vânia T M, Yoon, Sung-Soo, Beksac, Meral, Dimopoulos, Meletios Athanasios, Elghandour, Ashraf, Jedrzejczak, Wieslaw Wiktor, Günther, Andreas, Nakorn, Thanyaphong Na, Siri

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 465 KB

english, 2014

48

Bevacizumab alone or in combination with chemotherapy in glioblastomas?

Raza, Shahzad, Firwana, Belal, Doll, Donald C

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 43 KB

english, 2014

49

Cervical screening rates lower in HPV-vaccinated women

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 94 KB

english, 2014

50

Correction to Lancet Oncol 2014; 15: 1039

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 36 KB

english, 2014

51

Correction to Lancet Oncol 2014; 15: 1047

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 36 KB

english, 2014

52

Correction to Lancet Oncol 2014; 15: 1047–48

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 36 KB

english, 2014

53

Correction to Lancet Oncol 2014; 15: 1109–18

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 36 KB

english, 2014

54

Correction to Lancet Oncol 2014; 15: 1239

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 36 KB

english, 2014

55

Correction to Lancet Oncol 2014; 15: 1147–56

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 36 KB

english, 2014